A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

The canonical role of messenger RNA (mRNA) is to deliver protein-coding information to sites of protein synthesis. However, given that microRNAs bind to RNAs, we hypothesized that RNAs could possess a regulatory role that relies on their ability to compete for microRNA binding, independently of their protein-coding function. As a model for the protein-coding-independent role of RNAs, we describe the functional relationship between the mRNAs produced by the PTEN tumour suppressor gene and its pseudogene PTENP1 and the critical consequences of this interaction. We find that PTENP1 is biologically active as it can regulate cellular levels of PTEN and exert a growth-suppressive role. We also show that the PTENP1 locus is selectively lost in human cancer. We extended our analysis to other cancer-related genes that possess pseudogenes, such as oncogenic KRAS. We also demonstrate that the transcripts of protein-coding genes such as PTEN are biologically active. These findings attribute a novel biological role to expressed pseudogenes, as they can regulate coding gene expression, and reveal a non-coding function for mRNAs.

[1]  S. Gitelman,et al.  Abundant adrenal-specific transcription of the human P450c21A "pseudogene". , 1993, The Journal of biological chemistry.

[2]  G. Lozanski,et al.  Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. , 1995, Journal of immunology.

[3]  M. Wigler,et al.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Matthay,et al.  Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. , 1997, The American journal of pathology.

[5]  J. Bolen,et al.  Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN , 1999, Oncogene.

[6]  P. Pandolfi,et al.  Impaired Fas response and autoimmunity in Pten+/- mice. , 1999, Science.

[7]  S. Thorgeirsson,et al.  Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization , 1999, Hepatology.

[8]  A. Moreau-Aubry,et al.  A Processed Pseudogene Codes for a New Antigen Recognized by a Cd8+ T Cell Clone on Melanoma , 2000, The Journal of experimental medicine.

[9]  A. Baron,et al.  Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia , 2002, Leukemia.

[10]  P. Pandolfi,et al.  Pten Dose Dictates Cancer Progression in the Prostate , 2003, PLoS biology.

[11]  A. Moll,et al.  Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group , 2003, Journal of clinical pathology.

[12]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[13]  G. Batist,et al.  Connexin43 pseudogene is expressed in tumor cells and inhibits growth , 2004, Oncogene.

[14]  Cecilia Saccone,et al.  Pseudogenes in metazoa: origin and features. , 2004, Briefings in functional genomics & proteomics.

[15]  G. Chirn,et al.  Multiple Retropseudogenes from Pluripotent Cell-specific Gene Expression Indicates a Potential Signature for Novel Gene Identification* , 2005, Journal of Biological Chemistry.

[16]  K. Livak,et al.  Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.

[17]  M. Gerstein,et al.  Transcribed processed pseudogenes in the human genome: an intermediate form of expressed retrosequence lacking protein-coding ability , 2005, Nucleic acids research.

[18]  P. Pandolfi,et al.  Role of the proto-oncogene Pokemon in cellular transformation and ARF repression , 2005, Nature.

[19]  Jin Han,et al.  Oct4 pseudogenes are transcribed in cancers. , 2005, Biochemical and biophysical research communications.

[20]  Jin Han,et al.  NANOGP8 is a retrogene expressed in cancers , 2006, The FEBS journal.

[21]  Jun Kawai,et al.  Pseudo–Messenger RNA: Phantoms of the Transcriptome , 2006, PLoS genetics.

[22]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[23]  Brian S. Roberts,et al.  The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Werner,et al.  MIR-206 regulates connexin43 expression during skeletal muscle development , 2006, Nucleic acids research.

[25]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[26]  A. Hatzigeorgiou,et al.  Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs , 2007, Science.

[27]  P. Pandolfi,et al.  The theory of APL revisited. , 2007, Current topics in microbiology and immunology.

[28]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[29]  M. Todesco,et al.  Target mimicry provides a new mechanism for regulation of microRNA activity , 2007, Nature Genetics.

[30]  Oliver H. Tam,et al.  Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes , 2008, Nature.

[31]  H. Namba,et al.  Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells , 2008, Cancer science.

[32]  D. Iliopoulos,et al.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.

[33]  Pier Paolo Pandolfi,et al.  Tenets of PTEN Tumor Suppression , 2008, Cell.

[34]  J. George,et al.  MicroRNA‐134 Modulates the Differentiation of Mouse Embryonic Stem Cells, Where It Causes Post‐Transcriptional Attenuation of Nanog and LRH1 , 2008, Stem cells.

[35]  E. Lai,et al.  The long and short of inverted repeat genes in animals: MicroRNAs, mirtrons and hairpin RNAs , 2008, Cell cycle.

[36]  Yvonne Tay,et al.  MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation , 2008, Nature.

[37]  M. Gerstein,et al.  Comparative analysis of processed ribosomal protein pseudogenes in four mammalian genomes , 2009, Genome Biology.

[38]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[39]  N. Colburn,et al.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.

[40]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[41]  Huan Yang,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.

[42]  A. Børresen-Dale,et al.  COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.

[43]  N. Lau,et al.  A Broadly Conserved Pathway Generates 3′UTR-Directed Primary piRNAs , 2009, Current Biology.

[44]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[45]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[46]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[47]  G. Pan,et al.  MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.

[48]  Andrea Ventura,et al.  MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.

[49]  D. Bartel,et al.  Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression , 2009, Nature Biotechnology.

[50]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[51]  Reuven Agami,et al.  The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. , 2009, Genes & development.

[52]  M. Zou,et al.  Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors. , 2009, Neoplasia.

[53]  Hervé Seitz,et al.  Redefining MicroRNA Targets , 2009, Current Biology.

[54]  Oliver Hofmann,et al.  miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.

[55]  Lan Jin,et al.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. , 2009, Nature structural & molecular biology.

[56]  Burton B. Yang,et al.  A 3′-Untranslated Region (3′UTR) Induces Organ Adhesion by Regulating miR-199a* Functions , 2009, PloS one.

[57]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[58]  J. Rossi,et al.  TGF-β activates Akt kinase via a microRNA-dependent amplifying circuit targeting PTEN , 2009, Nature Cell Biology.

[59]  Pier Paolo Pandolfi,et al.  Subtle variations in Pten dose determine cancer susceptibility , 2010, Nature Genetics.

[60]  J. Maguire,et al.  Integrative analysis of the melanoma transcriptome. , 2010, Genome research.